SCYNEXIS Inc (SCYX)
1.77
-0.01
(-0.56%)
USD |
NASDAQ |
May 03, 16:00
1.78
+0.01
(+0.56%)
After-Hours: 20:00
SCYNEXIS Profit Margin (Quarterly): -337.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -337.9% |
| September 30, 2023 | -99.77% |
| June 30, 2023 | 93.01% |
| March 31, 2023 | -3.00K% |
| December 31, 2022 | -946.8% |
| September 30, 2022 | -1.90K% |
| June 30, 2022 | -1.01K% |
| March 31, 2022 | -793.4% |
| December 31, 2021 | -4.90K% |
| September 30, 2021 | -117.2% |
| June 30, 2021 | |
| March 31, 2021 | -38.80% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -14.74K% |
| March 31, 2019 | -35.79K% |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | -16.81K% |
| March 31, 2018 | -6.25K% |
| December 31, 2017 | -11.86K% |
| September 30, 2017 | -13.13K% |
| June 30, 2017 | -6.56K% |
| March 31, 2017 | -7.61K% |
| December 31, 2016 | -5.39K% |
| September 30, 2016 | -17.54K% |
| June 30, 2016 | -12.70K% |
| March 31, 2016 | -11.22K% |
| December 31, 2015 | -13.11K% |
| September 30, 2015 | -13.05K% |
| June 30, 2015 | -14.84K% |
| March 31, 2015 | -9.82K% |
| December 31, 2014 | -289.0% |
| September 30, 2014 | -6.24K% |
| June 30, 2014 | |
| March 31, 2014 | 8.76% |
| December 31, 2013 | -591.6% |
| September 30, 2013 | -95.12% |
| June 30, 2013 | -63.96% |
| March 31, 2013 | -43.15% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.74K%
Minimum
Jun 2019
93.01%
Maximum
Jun 2023
-2.32K%
Average
-870.1%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 144.9% |
| Return on Assets | 56.82% |
| Return on Invested Capital | 93.53% |
| Gross Profit Margin (Quarterly) | -153.3% |
| Operating Margin (Quarterly) | -397.9% |
| Return on Net Operating Assets | 234.9% |